The stock has a 36-month beta value of 1.99. Opinions on the stock are mixed, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for APLT is 88.20M, and at present, short sellers hold a 6.52% of that float. On July 01, 2024, the average trading volume of APLT was 844.00K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
APLT) stock’s latest price update
The stock of Applied Therapeutics Inc (NASDAQ: APLT) has increased by 1.52 when compared to last closing price of 4.60. Despite this, the company has experienced a 2.64% gain in its stock price over the last five trading sessions. benzinga.com reported 2024-06-11 that As of June 11, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
APLT’s Market Performance
APLT’s stock has risen by 2.64% in the past week, with a monthly rise of 11.99% and a quarterly drop of -31.32%. The volatility ratio for the week is 7.30% while the volatility levels for the last 30 days are 7.71% for Applied Therapeutics Inc The simple moving average for the past 20 days is 0.45% for APLT’s stock, with a 23.56% simple moving average for the past 200 days.
Analysts’ Opinion of APLT
Many brokerage firms have already submitted their reports for APLT stocks, with RBC Capital Mkts repeating the rating for APLT by listing it as a “Outperform.” The predicted price for APLT in the upcoming period, according to RBC Capital Mkts is $12 based on the research report published on March 26, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see APLT reach a price target of $12. The rating they have provided for APLT stocks is “Outperform” according to the report published on February 22nd, 2024.
Barclays gave a rating of “Equal Weight” to APLT, setting the target price at $7 in the report published on January 04th of the previous year.
APLT Trading at 3.60% from the 50-Day Moving Average
After a stumble in the market that brought APLT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -50.27% of loss for the given period.
Volatility was left at 7.71%, however, over the last 30 days, the volatility rate increased by 7.30%, as shares surge +6.14% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -3.31% lower at present.
During the last 5 trading sessions, APLT rose by +2.64%, which changed the moving average for the period of 200-days by +191.88% in comparison to the 20-day moving average, which settled at $4.66. In addition, Applied Therapeutics Inc saw 39.40% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at APLT starting from Shendelman Shoshana, who sale 61,795 shares at the price of $4.32 back on Jun 06 ’24. After this action, Shendelman Shoshana now owns 3,756,019 shares of Applied Therapeutics Inc, valued at $266,954 using the latest closing price.
Perfetti Riccardo, the Chief Medical Officer of Applied Therapeutics Inc, sale 22,003 shares at $4.32 during a trade that took place back on Jun 06 ’24, which means that Perfetti Riccardo is holding 1,009,534 shares at $95,053 based on the most recent closing price.
Stock Fundamentals for APLT
Current profitability levels for the company are sitting at:
- 156.75 for the present operating margin
- 2.47 for the gross margin
The net margin for Applied Therapeutics Inc stands at 405.79. The total capital return value is set at -1.11. Equity return is now at value -682.16, with -189.48 for asset returns.
Based on Applied Therapeutics Inc (APLT), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -195.61. The debt to equity ratio resting at 0.01. The interest coverage ratio of the stock is -103.71.
Currently, EBITDA for the company is -64.18 million with net debt to EBITDA at 3.26. When we switch over and look at the enterprise to sales, we see a ratio of -812.34. The receivables turnover for the company is -1.82for trailing twelve months and the total asset turnover is -0.0. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.80.
Conclusion
To sum up, Applied Therapeutics Inc (APLT) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
